Renal handling of circulating and renal-synthesized hepcidin and its protective effects against hemoglobin-mediated kidney injury

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2720-2732

  Van Swelm, Rachel P L ^a,b   Wetzels, Jack F M ^c   Verweij, Vivienne G M ^b   Laarakkers, Coby M M ^a   Pertijs, Jeanne C L M ^b   Van Der Wijst, Jenny ^a   Thévenod, Frank ^d   Masereeuw, Rosalinde ^b,e   Swinkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Pharmacology and Toxicology   (Netherlands)

^c Nephrology   (Netherlands)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; KIDNEY INJURY MOLECULE 1; MEGALIN; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; HEPCIDIN 25, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCYTOSIS; GENE EXPRESSION; GLOMERULUS; HAMP1 GENE; IMMUNOHISTOCHEMISTRY; KIDNEY DISTAL TUBULE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MALE; MASS SPECTROMETRY; MOUSE; NGAL GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; URINARY EXCRETION; URINE LEVEL; ACUTE KIDNEY INJURY; ANIMAL; C57BL MOUSE; KIDNEY; METABOLISM; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; HEMOGLOBINS; HEPCIDINS; KIDNEY; KIDNEY TUBULES, PROXIMAL; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-2; MALE; MICE; MICE, INBRED C57BL;

EID: 84995935339     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015040461     Document Type: Conference Paper

References (51)

1. Ho J, ReslerovaM, Gali B, Gao A, Bestland J, Rush DN, Nickerson PW, Rigatto C: Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass. Clin J Am Soc Nephrol 6: 2340-2346, 2011
2. Prowle JR, Ostland V, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Bagshaw SM, Haase-Fielitz A, Haase M, Westerman M, Bellomo R: Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass. Nephrol Dial Transplant 27: 595-602, 2012
3. Haase-Fielitz A,Mertens PR, PlassM, KuppeH,Hetzer R,Westerman M, Ostland V, Prowle JR, Bellomo R, Haase M: Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: An observational cohort study. Crit Care 15: R186, 2011
4. Haase M, Bellomo R, Haase-Fielitz A: Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypassassociated acute kidney injury. J Am Coll Cardiol 55: 2024-2033, 2010
5. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004
6. Farnaud S, Patel A, Evans RW: Modelling of a metal-containing hepcidin. Biometals 19: 527-533, 2006
7. Gerardi G, Biasiotto G, Santambrogio P, Zanella I, Ingrassia R, Corrado M, Cavadini P, Derosas M, Levi S, Arosio P: Recombinant human hepcidin expressed in Escherichia coli isolates as an iron containing protein. Blood Cells Mol Dis 35: 177-181, 2005
8. Farnaud S, Rapisarda C, Bui T, Drake A, Cammack R, Evans RW: Identification of an iron-hepcidin complex. Biochem J 413: 553-557, 2008
9. Ho J, Lucy M, Krokhin O, Hayglass K, Pascoe E, Darroch G, Rush D, Nickerson P, Rigatto C, Reslerova M: Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass:Anested case-control study. AmJ KidneyDis 53: 584-595, 2009
10. Itkonen O, Stenman UH, Parkkinen J, Soliymani R, Baumann M, Hämäläinen E: Binding of hepcidin to plasma proteins. Clin Chem 58: 1158-1160, 2012
11. PeslovaG, Petrak J, Kuzelova K,Hrdy I, Halada P, KuchelPW, Soe-Lin S, Ponka P, Sutak R, Becker E, Huang ML, Suryo Rahmanto Y, Richardson DR, Vyoral D: Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood 113: 6225-6236, 2009
12. Huang ML, Austin CJ, Sari MA, Rahmanto YS, Ponka P, Vyora l D, RichardsonDR:Hepcidin bound toa2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels. J Biol Chem 288: 25450-25465, 2013
13. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T: Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106: 2196-2199, 2005
14. Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, Janetzko A, Cetin Y, Stremmel W: The iron-regulatory peptide hormone hepcidin: Expression andcellular localization in themammalian kidney. J Endocrinol 184: 361-370, 2005
15. Houamel D, Ducro t N, Lefebvre T, Daher R, Moulouel B, Sari MA, Letteron P, Lyoumi S, Millot S, Tourret J, Bouvet O, Vaulont S, Vandewalle A, Denamur E, Puy H, Beaumont C, Gouya L, Karim Z: Hepcidin as a major component of renal antibacterial defenses against uropathogenic Escherichia coli [published online ahead of print August 20, 2015]. J Am Soc Nephrol doi:ASN. 2014101035
16. Ganz T,OlbinaG, Girelli D, Nemeth E,WestermanM: Immunoassay for human serum hepcidin. Blood 112: 4292-4297, 2008
17. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, Tjalsma H: Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 3: e2706, 2008
18. Peters HP, Laarakkers CM, Pickkers P, Masereeuw R, Boerman OC, Eek A, Cornelissen EA, Swinkels DW, Wetzels JF: Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol 14: 70, 2013
19. Kemna EH, Tjalsma H, Podust VN, Swinkels DW: Mass spectrometrybased hepcidin measurements in serum and urine: Analytical aspects and clinical implications. Clin Chem 53: 620-628, 2007
20. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW: Hepcidin in human iron disorders: Diagnostic implications. Clin Chem 57: 1650-1669, 2011
21. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001
22. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T: The Nterminus of hepcidin is essential for its interaction with ferroportin: Structure-function study. Blood 107: 328-333, 2006
23. van Eerd JE, Vegt E,Wetzels JF, Russel FG,Masereeuw R, Corstens FH, Oyen WJ, Boerman OC: Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. J Nucl Med 47: 528-533, 2006
24. Campostrini N, Traglia M, Martinelli N, Corbella M, Cocca M, Manna D, Castagna A, Masciullo C, Silvestri L, Olivieri O, Toniolo D, Camaschella C, Girelli D: Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. J Proteomics 76: 28-35, 2012
25. Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, Tjalsma H, Swinkels DW: Improved mass spectrometry assay for plasma hepcidin: Detection and characterization of a novel hepcidin isoform. PLoS One 8: e75518, 2013
26. Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J: The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156: 1527-1535, 2000
27. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003
28. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F: Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 28: 436-440, 2010
29. Chen J, Hartono JR, John R, Bennett M, Zhou XJ, Wang Y, Wu Q, Winterberg PD, Nagami GT, Lu CY: Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 80: 504-515, 2011
30. Wilmer MJ, Saleem MA, Masereeuw R, Ni L, van der Velden TJ, Russel FG, Mathieson PW, Monnens LA, van den Heuvel LP, Levtchenko EN: Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters . Cell Tissue Res 339: 449-457, 2010
31. Gorvin CM, WilmerMJ, Piret SE, Harding B, van den Heuvel LP,Wrong O, Jat PS, Lippiat JD, Levtchenko EN, Thakker RV: Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients. Proc Natl Acad Sci U S A 110: 7014-7019, 2013
32. Kartikasari AE, Roelofs R, Schaeps RM, Kemna EH, PetersWH, Swinkels DW, Tjalsma H: Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways. Biochim Biophys Acta 1784: 2029-2037, 2008
33. Schranz M, Bakry R, Creus M, Bonn G, Vogel W, Zoller H: Activation and inactivation of the iron hormone hepcidin: Biochemical characterization of prohepcidin cleavage and sequential degradation to N-terminally truncated hepcidin isoforms. Blood Cells Mol Dis 43: 169-179, 2009
34. Kenny AJ, Booth AG, George SG, Ingram J, Kershaw D, Wood EJ, Young AR: Dipeptidyl peptidase IV, a kidney brush-border serine peptidase. Biochem J 157: 169-182, 1976
35. Rosen S, Stillman IE: Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol 19: 871-875, 2008
36. Scindia Y, Dey P, Thirunagari A, Liping H, RosinDL, FlorisM,OkusaMD, Swaminathan S: Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. JAmSocNephrol 26: 2800-2814, 2015
37. Gburek J, Verroust PJ, Willnow TE, Fyfe JC, Nowacki W, Jacobsen C, Moestrup SK, Christensen EI: Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J AmSocNephrol 13: 423-430, 2002
38. Gozzelino R, Soares MP: Coupling heme and iron metabolism via ferritin H chain. Antioxid Redox Signal 20: 1754-1769, 2014
39. Paller MS: Hemoglobin-and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol 255: F539-F544, 1988
40. Zager RA, Gamelin LM: Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. AmJ Physiol 256: F446-F455, 1989
41. Gutteridge JM: Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201: 291-295, 1986
42. Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Rawn JD, Frendl G, Waikar SS: Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery. Kidney Int 87: 1046-1054, 2015
43. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309, 2000
44. Zarjou A, Bolisetty S, Joseph R, Traylor A, Apostolov EO, Arosio P, Balla J, Verlander J, Darshan D, Kuhn LC, Agarwal A: Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest 123: 4423-4434, 2013
45. Leheste JR, Melsen F, Wellner M, Jansen P, Schlichting U, Renner-Müller I, Andreassen TT, Wolf E, Bachmann S, Nykjaer A, Willnow TE: Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 17: 247-249, 2003
46. Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML: Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29: 52-54, 2000
47. Tjalsma H, LaarakkersCM, van SwelmRP, TheurlM, Theurl I, Kemna EH, van der Burgt YE, Venselaar H, Dutilh BE, Russel FG, Weiss G, Masereeuw R, Fleming RE, SwinkelsDW:Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One 6: e16762, 2011
48. Torrance JD, Bothwell TH: A simple technique for measuring storage iron concentrations in formalinised liver samples. S AfrJMedSci 33: 9-11, 1968
49. Jansen J, Schophuizen CM, Wilmer MJ, Lahham SH, Mutsaers HA, Wetzels JF, Bank RA, van denHeuvel LP, Hoenderop JG,MasereeuwR: A morphological and functional comparison of proximal tubule cell lines established fromhuman urine and kidney tissue. Exp Cell Res 323: 87-99, 2014
50. Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, Horisberger JD, Rossier BC:Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosteronestimulated sodiumtransport in a novel renal cell line. J AmSocNephrol 16: 878-891, 2005
51. AbouhamedM,Wolff NA, Lee WK, Smith CP, Thévenod F: Knockdown of endosomal/lysosomal divalent metal transporter 1 by RNA interference prevents cadmium-metallothionein-1 cytotoxicity in renal proximal tubule cells. AmJ Physiol Renal Physiol 293: F705-F712, 2007